Zapała, P., Garbas, K., Lewandowski, Z., Ślusarczyk, A., Ślusarczyk, C., & Mielczarek, Ł., et al. (2023). Neutrophil-to-lymphocyte ratio predicts nodal involvement in unfavourable, clinically nonmetastatic prostate cancer patients and overall survival in pN1 patients. Scientific Reports, 13(1), 392 (1–8).

Article  PubMed  PubMed Central  Google Scholar 

Vandekerkhove, G., Chi, K. N., & Wyatt, A. W. (2018). Clinical utility of emerging liquid biomarkers in advanced prostate cancer. Cancer Genetics, 228–229, 151–158.

Article  PubMed  Google Scholar 

SopeñaSutil, R., Gómez Grande, A., González Díaz, A., Téigel Tobar, J., Cabeza Rodríguez, M. Á., & González Billalabeitia, E., et al. (2022). Role of F-Choline PET/CT in the initial staging of high risk prostate cancer and comparison with conventional imaging techniques. Archivos Espanoles de Urologia, 75(8), 684–692.

Article  Google Scholar 

Wu, J., Guo, S., Wang, L., & Liao, Z. (2022). Correlation analysis between CD133, Klk3 and grhl2 expression and tumor characteristics in prostate cancer. Cellular and Molecular Biology, 67(6), 68–73.

Article  PubMed  Google Scholar 

Piramide, F., Bravi, C. A., Turri, F., DI Maida, F., Andras, I., & Lambert, E., et al. (2022). ERUS/YA U Working Group on Robot-assisted Surgery of the European Association of Urology. Retzius-sparing robot-assisted radical prostatectomy in high-risk prostate cancer: can it be as effective as the anterior approach in such a challenging setting? Cellular and Molecular Biology, 74(6), 807–809.

Google Scholar 

Ertl, I. E., Brettner, R., Kronabitter, H., Mohr, T., Derdak, S., & Jeitler, M., et al. (2022). The SMARCD family of SWI/SNF accessory proteins is involved in the transcriptional regulation of androgen receptor-driven genes and plays a role in various essential processes of prostate cancer. Cell Press, 12(1), 124.

Google Scholar 

Gloger, S., Ubrig, B., Boy, A., Leyh-Bannurah, S. R., Siemer, S., Arndt, M., & Stolzenburg, J. U., et al. (2022). Bilateral peritoneal flaps reduce incidence and complications of lymphoceles after robotic radical prostatectomy with pelvic lymph node dissection-results of the prospective randomized multicenter trial proly. Journal of Urology, 208(2), 333–340.

Article  PubMed  Google Scholar 

Nicolopoulos, K., Moshi, M. R., Stringer, D., Ma, N., Jenal, M., & Vreugdenburg, T. (2023). The clinical effectiveness of denosumab (Prolia®) in patients with hormone-sensitive cancer receiving endocrine therapy, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysis. Archives of Osteoporosis, 18(1), 18.

Article  PubMed  Google Scholar 

HLi, R., Liu, H., Dilger, J. P., & Lin, J. (2018). Effect of Propofol on breast Cancer cell, the immune system, and patient outcome. BMC Anesthesiology, 18(1), 77.

Article  Google Scholar 

Liu, H. (2023). Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma. Cancer Genetics, 274-275, 21–25.

Article  CAS  PubMed  Google Scholar 

Chamoto, K., Wakita, D., Narita, Y., Zhang, Y., Noguchi, D., & Ohnishi, H., et al. (2006). An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy. Cancer Research, 66(3), 1809–1817.

Article  CAS  PubMed  Google Scholar 

Yan, X. H., Dong, Q. L., Jin, G., Zhu, Y. N., & Zhang, L. P. (2021). Effect of interleukin-17 gene on glomerular ultrastructure and podocyte injury in adriamycin nephropathy rat models. Journal of Biological Regulators and Homeostatic Agents, 35(3), 1001–1010.

CAS  PubMed  Google Scholar 

Wang, W., Wang, X., Yang, W., Zhong, K., He, N., & Li, X., et al. (2021). A CTLA-4 blocking strategy based on Nanoboby in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects. BioMed Central, 21(1), 1029.

CAS  Google Scholar 

Golay, J., Martinelli, S., Alzani, R., Cribioli, S., Albanese, C., & Gotti, E., et al. (2018). Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19 tumors. Cytotherapy, 20(8), 1077–1088.

Article  CAS  PubMed  Google Scholar 

Zhou, L., Chen, Q., Chen, H., Wang, L., & Zhang, J. (2022). Enhanced inhibitory effect of DC-CIK cells on lung adenocarcinoma via Anti-Tim-3 antibody and antiprogrammed cell death-1 antibody and possible mechanism. Evidence-based Complementary and Alternative Medicine, 2022, 4097576.

PubMed  PubMed Central  Google Scholar 

Chomchoei, C., Brimson, J. M., & Brimson, S. (2022). Repurposing fluoxetine to treat lymphocytic leukemia: apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert Opinion on Therapeutic Targets, 26(12), 1087–1097.

Article  CAS  PubMed  Google Scholar 

Naseer, F., Ahmad, T., Kousar, K., Kakar, S., Gul, R., & Anjum, S., et al. (2023). Formulation for the targeted delivery of a vaccine strain of Oncolytic Measles Virus (OMV) in hyaluronic acid coated thiolated chitosan as a green nanoformulation for the treatment of prostate cancer: a viro-immunotherapeutic approach. International Journal Of Nanomedicine, 18, 185–205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, R., Li, Y., Wu, H., Liu, B., Zhang, X., & Zhang, Z. (2023). 68Ga-PSMA-11 PET/CT versus 68Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis. Frontiers in Oncology, 13, 1216894.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, S., Yuan, J., Xie, Y., Qing, K., Shi, Z., & Chen, G., et al. (2023). Targeting nano-regulator based on metal–organic frameworks for enhanced immunotherapy of bone metastatic prostate cancer. Cancer Nanotechnology, 14(1), 43.

Article  CAS  Google Scholar 

Gao, Y., Liu, Y., Liu, Y., Peng, Y., Yuan, B., & Fu, Y., et al. (2021). UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications. Cancer Letters, 520, 172–183.

Article  CAS  PubMed  Google Scholar 

Lu, M., Wei, F., Ma, S., Xu, Z., Wang, J., Yang, C., & Mao, L. (2021). Oncolytic Virus as a Novel Modality for the Treatment of Prostate Cancer. Discovery Medicine, 32(167), 133–139.

PubMed  Google Scholar 

Kim, K. S., Choi, B., Choi, H., Ko, M. J., Kim, D. H., & Kim, D. H. (2022). Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer. Journal of Nanobiotechnology, 20(1), 428.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong, Y., Gao, S., Zhang, X., Kou, J., Liu, J., Ye, T., & Shen, H. (2022). CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration. Anti-cancer Drugs, 33(2), 149–157.

Article  CAS  PubMed  Google Scholar 

Zhang, Z., Xiong, L., Wu, Z., Liu, H., Ning, K., & Peng, Y., et al. (2021). Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma. Translational Andrology and Urology, 10(5), 2091–2102.

Article  PubMed  PubMed Central  Google Scholar 

Chen, S., Yang, Y., Jiao, Y., Sun, H., & Yan, Z. (2021). Capecitabine metronomic chemotherapy combined with autologous CIK cell immunotherapy in the treatment of recurrent and metastatic triple-negative breast cancer. Journal of BUON, 26(3), 734–740.

PubMed  Google Scholar 

Xu, H., Qin, W., Feng, H., Song, D., Yang, X., & Zhang, J. (2021). Analysis of the clinical efficacy of dendritic cell -cytokine induced killer cell-based adoptive immunotherapy for colorectal cancer. Immunological investigations, 50(6), 622–633.

Article  CAS  PubMed  Google Scholar 

Zhang, Y., Wu, X., Sharma, A., Weiher, H., Schmid, M., & Kristiansen, G., et al. (2022). Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma. Frontiers in Immunology, 13, 925633.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pietraforte, I., Butera, A., Gaddini, L., Mennella, A., Palazzo, R., & Campanile, D., et al. (2022). CXCL4-RNA complexes circulate in systemic sclerosis and amplify inflammatory/pro-fibrotic responses by myeloid dendritic cells. International Journal of Molecular Sciences, 24(1), 653.

Article  PubMed  PubMed Central  Google Scholar 

Singh, S., Maurya, S. K., Aqdas, M., Bashir, H., Arora, A., & Bhalla, V., et al. (2022). Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system. Cellular and molecular life sciences, 79(11), 567.

Article  CAS  PubMed  Google Scholar 

Dehno, M. N., Li, Y., Weiher, H., & Schmidt-Wolf, I. G. H. (2020). Increase in efficacy of checkpoint inhibition by cytokine-induced-killer cells as a combination immunotherapy for renal cancer. International Journal of Molecular Sciences, 21(9), 3078.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fayyaz, F., Yazdanpanah, N., & Rezaei, N. (2022). Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer. Cell Communication and Signaling, 20(1), 41.

Article  CAS